Description
A fusidane antibiotic; active against a variety of Gram-positive bacteria (MIC50s = 0.01-20 µg/ml) but not Gram-negative bacteria or fungi (MIC50s = >100 µg/ml for all); inhibits EF-G-mediated ribosomal recycling and protein translocation in isolated E. coli ribosomes (IC50s = ~0.1 and ~200 µM, respectively); reduces the number of skin CFUs and levels of TNF-α and IL-6 in a mouse model of MRSA skin wound infection
Formal name: (4α,8α,9β,13α,14β)-16β-(acetyloxy)- 3α,11α-dihydroxy-29-nordammara-17Z(20),24-dien-21-oic acid, monosodium salt
Synonyms: SQ 16,360
Molecular weight: 538.7
CAS: 751-94-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Antibiotics||Product Type|Biochemicals|Natural Products|Microbial Metabolites||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Epigenetics, Transcription, & Translation|RNA, DNA, & Protein Synthesis||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases